Skip to content
Home/Companies/Biotech/Arriva Pharmaceuticals

Arriva Pharmaceuticals

Biotech·United States·Active·18yr hold
Entry
2008
Hold
18yr
Status
Active

Who owns Arriva Pharmaceuticals?

Arriva Pharmaceuticals is an American Biotech company, currently owned by Nordic Biotech Advisors since 2008.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Biotech Advisors
Investor
Nordic Biotech Advisors
Nordic Biotech II K/S · 2006 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More Nordic Biotech Advisors portfolio companies

From the same investor, across funds.

Forward Pharma
Exited 2014
BiotechDenmark· 2006
Curalogic
Exited 2006
BiotechDenmark· 2004
Gastrotech Pharma
Active
BiotechDenmark· 2003
Osteologix
Exited 2006
BiotechDenmark· 2003
LifeCycle Pharma
Exited 2006
PharmaDenmark· 2002

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Arriva Pharmaceuticals?

Arriva Pharmaceuticals is currently owned by Nordic Biotech Advisors, through Nordic Biotech II K/S, since 2008.

When did Nordic Biotech Advisors acquire Arriva Pharmaceuticals?

Nordic Biotech Advisors acquired Arriva Pharmaceuticals in 2008.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue